Impaired cellular immune response to tetanus toxoid but not to cytomegalovirus in effectively HAART-treated HIV-infected children
Abstract
No abstract availableKeywords
Funding Information
- Universitat de Barcelona
- FIS (99/0051-01)
This publication has 14 references indexed in Scilit:
- Immunogenicity, Immunologic Memory, and Safety Following Measles Revaccination in HIV-Infected Children Receiving Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2012
- Guidance on vaccination of HIV‐infected children in EuropeHIV Medicine, 2012
- Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndromeJournal of Allergy and Clinical Immunology, 2010
- Do children infected with HIV receiving HAART need to be revaccinated?The Lancet Infectious Diseases, 2010
- Susceptibility to opportunistic infections in HIV‐infected patients with increased CD4 T‐cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cellsHIV Medicine, 2007
- Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART)European Journal of Pediatrics, 2006
- Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infectionJournal of Allergy and Clinical Immunology, 2005
- Immunogenicity and efficacy of childhood vaccines in HIV-1-infected childrenThe Lancet Infectious Diseases, 2004
- Response to Immunization With Measles, Tetanus, andHaemophilus influenzaeType b Vaccines in Children Who Have Human Immunodeficiency Virus Type 1 Infection and Are Treated With Highly Active Antiretroviral TherapyPediatrics, 2003
- Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected childrenThe Pediatric Infectious Disease Journal, 2003